Rafarma Pharmaceuticals Stock Pattern Recognition Doji

RAFA Stock

USD 0.07 -0.01 -6.94%

The pattern recognition module provides an execution environment for Doji recognition and related indicators on Rafarma Pharmaceuticals. Signals here center on pattern recognition signals tied to momentum and continuation alongside volatility and performance references.

Symbol

Recognition

The output start index for this execution was ten with a total number of output elements of fifty-one. The function generated a total of thirty valid pattern recognition events for the selected time horizon. The Doji is candlestick pattern analysis indicator that fired when Rafarma Pharmaceuticals open and close prices are equal. It suggests that the direction of Rafarma Pharmaceuticals's trend maybe be nearing a turning point.

Rafarma Pharmaceuticals Technical Analysis Modules

Most technical analysis of Rafarma Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Rafarma from various momentum indicators to cycle indicators. When you analyze Rafarma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Pink Sheet Overview, Methodology & Data Sources

Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. D. RAFARMA PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. The profile for Rafarma Pharmaceuticals integrates fundamentals, price behavior, and sector exposure. Price behavior may show elevated responsiveness to broader market cycles. Rafarma Pharmaceuticals has a market cap of 110.29 M, ROE of -0.07%.

Methodology

Unless otherwise specified, financial data for Rafarma Pharmaceuticals is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Rafarma (USA Stocks:RAFA) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information presented is compiled from public filings and market reference sources and official institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR. Updates can be delayed depending on reporting conventions. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Rafarma Pharmaceuticals may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board

Become your own money manager

Tracking Rafarma Pharmaceuticals inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Portfolio Analyzer Now

Portfolio Analyzer

Portfolio analysis module that provides access to portfolio diagnostics and optimization engine

All Next

Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.

	Corona Opportunity Invested few shares	Go
	Investor Favorites Invested over 20 shares	Go
	Macroaxis Index Invested over 60 shares	Go
	Driverless Cars Invested few shares	Go
	Artificial Intelligence Invested few shares	Go
	Disruptive Technologies Invested few shares	Go
	Cash Cows Invested few shares	Go
	Hedge Favorites Invested over 200 shares	Go
	Advertising Invested few shares	Go
	Social Domain Invested few shares	Go
	Warren Buffett Holdings Invested over 20 shares	Go
	Blockchain Invested few shares	Go

More Resources for Rafarma Pink Sheet Analysis

Other Information on Investing in Rafarma Pink Sheet

Rafarma Pharmaceuticals financial ratios help frame valuation context across profits, cash flow, and enterprise value. They help compare Rafarma across measures in a consistent way.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC